Last updated on November 2019

A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma

Brief description of study

This is a study to test the safety and effectiveness of the study drug, daratumumab in combination with carfilzomib, lenalidomide and dexamethasone. The purpose of this study is to test whether giving daratumumab along with the other drugs (carfilzomib, lenalidomide and dexamethasone) is safe for patients.

Clinical Study Identifier: NCT03290950

Find a site near you

Start Over